The Precision Peptide Company Inc. (CSE:BPC)
Canada · Delayed Price · Currency is CAD 0.2900
-0.0300 (-9.38%)
Oct 30, 2026, 2:40 PM EDT
CSE:BPC Revenue
The Precision Peptide Company had revenue of 64.14K CAD in the quarter ending July 31, 2026, with 984.20% growth. This brings the company's total for the last twelve months to 167.35K, up 2,292.02% year-over-year. In the fiscal year ending October 31, 2025, The Precision Peptide Company had annual revenue of 49.72K with 307.47% growth. That makes The Precision Peptide Company the 45,911th largest company in the world by revenue and 1,052nd in Canada.
Revenue (ttm)
167.35K
Revenue Growth
+2,292.02%
P/S Ratio
96.41
Revenue / Employee
n/a
Employees
2
Market Cap
16.13M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Oct 31, 2025 | 49.72K | 37.52K | 307.47% |
| Oct 31, 2024 | 12.20K | -273.39K | -95.73% |
| Oct 31, 2023 | 285.59K | -295.40K | -50.84% |
| Oct 31, 2022 | 580.99K | 463.57K | 394.79% |
| Oct 31, 2021 | 117.42K | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Restaurant Brands International Limited Partnership | 13.88B |
| MTY Food Group | 1.12B |
| A & W Food Services of Canada | 302.47M |
| Boston Pizza Royalties Income Fund | 52.56M |
| Pizza Pizza Royalty | 40.09M |
| Happy Belly Food Group | 27.84M |
| Aegis Brands | 16.91M |
| Purebread Brands | 14.49M |
The Precision Peptide Company News
- 1 day ago - The Precision Peptide Company Quadruples U.S. Telehealth Formulary to 16 Prescription Therapies Across Seven Therapy Areas - Newsfile Corp
- 2 days ago - The Precision Peptide Company Highlights 30 Years of Peptide Science Behind Its Product Platform - Newsfile Corp
- 8 days ago - The Precision Peptide Company Locks In Exclusive Manufacturing Rights Across Its Needle-Free Line - Newsfile Corp
- 10 days ago - The Precision Peptide Company Begins Development of GLP3 Patch, Its Fourth Needle-Free Peptide - Newsfile Corp
- 17 days ago - The Precision Peptide Company Advances Needle-Free GLP-1 Tirzepatide Patch into Formal U.S. Testing - Newsfile Corp
- 22 days ago - RETRANSMISSION: The Precision Peptide Company Orders 20,000 Thymosin Alpha-1 Patches for Commercial Launch - Newsfile Corp
- 23 days ago - The Precision Peptide Company Orders 20,000 Thymosin Alpha-1 Patches for Commercial Launch - Newsfile Corp
- 4 weeks ago - The Precision Peptide Company Expands U.S. Wholesale Program, Opening Distribution of Its Needle-Free Range to Clinics, Med Spas, Gyms and Retailers - Newsfile Corp